Asep Medical Holdings Inc (ASEP.CN) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+1594.5%

CA$1.69

vs CA$0.10 price

Levered DCF

-CA$0.56

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

-5.66

Distress zone

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-0.58×	-0.5×	-15.77×	-6.4×	-121.95×	-5,263.16×	-422,254.5×
P/B	1.24×	0.85×	10.12×	2.32×	15.37×	-990.21×	-1,217.45×
P/S	8.56×	14.05×	6,035.12×	0×	0×	0×	2,436.62×
EV / EBITDA	-1.6×	-1.9×	-15.68×	-7.41×	-133.39×	376,736.88×	0×
Gross margin	-111.2%	100.0%	-538.0%	0.0%	0.0%	0.0%	10.1%
Operating margin	-761.4%	-1307.9%	-36524.4%	0.0%	0.0%	0.0%	-0.6%
Net margin	-1459.7%	-2779.8%	-38918.3%	0.0%	0.0%	0.0%	-0.6%
Current ratio	0.12×	0.02×	0.25×	6.43×	39.9×	0.07×	0.02×
Debt / equity	0.1×	0.06×	0×	0×	0×	-0.93×	-0.9×
Interest coverage	-96.96×	0×	-28,597.27×	-6,686.31×	-19.39×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-211.2%	-167.5%	-65.2%	-37.2%	-12.6%	18.7%	0.3%
Return on invested capital	-40.6%	-33.8%	-31.3%	-20.2%	-6.4%	286.2%	3.0%
Return on assets	-56.4%	-57.8%	-32.1%	-21.3%	-7.5%	-255.9%	-13.6%
Free cash flow yield	-35.3%	-8.1%	-2.1%	-10.1%	-0.5%	-0.0%	-0.0%
Earnings yield	-170.5%	-197.8%	-6.4%	-16.0%	-0.8%	-0.0%	-0.0%
Enterprise value	CA$3M	CA$4.5M	CA$127.5M	CA$33.8M	CA$275.4M	CA$149.2M	CA$149.2M
Net debt / EBITDA	-0.04×	-0.13×	0.01×	0.47×	2.56×	333.95×	0×
Cash conversion cycle (days)	-503	0	-720	-1,241	-297	-287	-95